查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2083678

次世代定序市場：按技術、產品類型、探針長度、最終用戶和應用分類－2026-2032年全球市場預測

Next Generation Sequencing Market by Technology, Product Type, Read Length, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，次世代定序市場將成長至 374.8 億美元，複合年成長率為 16.72%。

主要市場統計數據
基準年 2025 126.9億美元
預計年份：2026年 147.5億美元
預測年份 2032 374.8億美元
複合年成長率 (%) 16.72%

次世代定序已從專門的研究工作流程轉變為精準醫療、腫瘤學、遺傳疾病檢測、感染疾病監測、生殖醫學、藥物基因體學、農業和生物製造等領域的核心基礎設施。這一市場的發展得益於定序化學、樣品製備、實驗室自動化和雲端生物資訊學等領域的成熟進步，這些進步在縮短處理時間的同時，提高了通量、擴充性和讀取準確性。

在那些直接影響臨床效用、保險報銷、藥物研發效率和公共衛生價值的領域，新一代定序（NGS）的需求最為強勁。隨著越來越多的實驗室尋求能夠兼顧可靠數據生成、檢驗的解讀和安全數據管理的可擴展平台，NGS 在癌症基因分型、罕見疾病診斷、液態生物檢體研究、病原體基因組學、新生兒篩檢研究和人群規模定序項目等領域的應用日益廣泛。

一項將重新定義次世代定序的變革性變化。

NGS（新一代定序）領域正經歷三大結構性變革：一是定序環境從短讀長主導型轉變為長短讀長混合型生態系；二是分析環境從本地伺服器轉移到安全的雲端和混合環境；三是定序融入常規臨床決策流程。高通量測序儀目前服務於大規模人群研究項目，而桌上型和中通量測序系統則支援在醫院、社區和專業檢查室進行分散式檢查。

人工智慧對新一代定序技術的累積影響

人工智慧 (AI) 透過改善鹼基確定、變異優先排序、註釋、品管和臨床解讀，進一步提升了次世代定序 (NGS) 的價值。 AI 工具減輕了人工資料整理的負擔，識別定序偽影，檢測基因組和轉錄組資料中的複雜模式，並加速了大規模基因組、表觀基因和多體學資料集的解讀。

主要區域洞察

北美憑藉其強大的學術醫療中心、先進的參考檢查室網路、生物醫學領域的資金支持、臨床試驗活動以及測序定序在腫瘤學、罕見病、藥物基因體學和感染疾病的廣泛應用，仍然是新一代測序（NGS）領域的領先地區。歐洲受益於國家層級的基因組策略、成熟的生物樣本庫資源、癌症和罕見疾病項目，以及監管主導對資料保護和臨床品質的重視。其對健康數據的投入有望在未來促進負責任的跨國數據使用。

關鍵群體特定見解

在主要經濟和地緣政治集團中，七國集團（G7）在臨床應用、保險報銷體系、監管科學、基因組醫學計畫和先進定序基礎設施方面繼續發揮主導作用。歐盟則以其協調一致的健康數據政策、基因組網路、罕見疾病合作、癌症防控重點以及支持跨境研發和臨床應用的統一品質框架而脫穎而出。

主要國家的關鍵見解

美國是新一代定序（NGS）商業化的領先中心，這得益於先進的診斷技術、生物製藥行業的需求、學術醫學、公共衛生基因組學以及大規模人群研究計畫。加拿大透過癌症基因組學、新生兒和罕見疾病計畫以及公共資助的研究網路做出貢獻，而墨西哥和巴西則在拉丁美洲各地開展合作，以加強私人診斷、癌症檢測的可及性以及學術定序網路。

為行業領導者提供的實用建議

產業領導者應優先考慮能夠帶來可衡量的臨床、營運或研究成果的工作流程，而不是僅僅關注定序的成本競爭。商業性成功越來越依賴整合樣本製備、定序、生物資訊學、報告、資料安全、互通性、品質保證和監管文件的端到端解決方案。

調查方法

本執行摘要基於二手研究，數據來源包括監管機構、國家基因組計劃、公共衛生機構、同行評審文獻、臨床指南制定組織、檢驗報銷參考資料、政府健康資訊來源舉措以及已發表的科學合作項目。市場分析重點在於成熟技術的部署、政策方向、臨床應用案例、法規環境和基礎設施投資。

結論

次世代定序正成為數據驅動型醫學和生命科學領域的基礎技術。市場不再僅僅取決於定序的速度和成本，而是越來越取決於其將基因組數據轉化為可靠、可操作、安全且受監管的決策的能力，這些決策可應用於臨床、研究、公共衛生和工業等領域。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章次世代定序市場：依技術分類

  • 擴增子定序
  • 基因panel定序
  • RNA定序
  • 標靶定序
  • 全EXOME定序（WES）
  • 全基因測序（WGS）

第8章：次世代定序市場：依產品類型分類

  • 耗材和試劑
    • 酵素
    • 成套工具
  • 裝置
    • 輔助設備
    • 序列器
  • 軟體
  • 服務

第9章次世代定序市場：依探針長度分類

  • 短線
  • 長週期

第10章：次世代定序市場：依最終用戶分類

  • 學術研究機構
  • 醫療診斷檢測機構
  • 製藥和生物技術公司

第11章次世代定序市場：按應用領域分類

  • 農業基因組學
  • 表觀基因
  • 法醫學基因組學
  • 神經基因組學
  • 腫瘤學
  • 藥物基因體學

第12章次世代定序市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章次世代定序市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章次世代定序市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • QIAGEN NV
  • BGI Genomics Co., Ltd.
  • Oxford Nanopore Technologies plc.
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.
  • Takara Bio Inc.
  • Eurofins Genomics GmbH
  • Pacific Biosciences of California, Inc.
  • F. Hoffmann-La Roche Ltd
  • Novogene Co., Ltd.
  • MGI Tech Co., Ltd.
  • GenScript Biotech Corporation
  • 10x Genomics, Inc.
  • DNAnexus, Inc.
  • Element Biosciences, Inc.
  • Fabric Genomics, Inc.
  • Integrated DNA Technologies, Inc.
  • Macrogen, Inc.
  • PerkinElmer, Inc.
  • PierianDx, Inc.
  • SeqWell, Inc.
  • Singular Genomics Systems, Inc.
  • Strand Life Sciences Pvt. Ltd.
  • Ultima Genomics, Inc.
Product Code: MRR-4312A385A68A

The Next Generation Sequencing Market is projected to grow by USD 37.48 billion at a CAGR of 16.72% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 12.69 billion
Estimated Year [2026] USD 14.75 billion
Forecast Year [2032] USD 37.48 billion
CAGR (%) 16.72%

Next generation sequencing has moved from a specialized research workflow into a core infrastructure layer for precision medicine, oncology, inherited disease testing, infectious disease surveillance, reproductive health, pharmacogenomics, agriculture, and biomanufacturing. The market is supported by verified advances in sequencing chemistry, library preparation, laboratory automation, and cloud-based bioinformatics that have reduced turnaround time while increasing throughput, scalability, and read accuracy.

Demand is strongest where NGS links directly to clinical utility, reimbursement readiness, drug development productivity, and public health value. Cancer profiling, rare disease diagnosis, liquid biopsy research, pathogen genomics, newborn screening research, and population-scale sequencing programs continue to expand adoption as laboratories seek scalable platforms that combine reliable data generation with validated interpretation and secure data management.

Transformative Shifts Reshaping Next Generation Sequencing

The NGS landscape is being reshaped by three structural shifts: the move from short-read dominance to a mixed short-read and long-read ecosystem, the migration of analysis from local servers to secure cloud and hybrid environments, and the integration of sequencing into routine clinical decision-making. High-throughput instruments now support population-scale projects, while benchtop and mid-throughput systems enable decentralized testing in hospital, regional, and specialty laboratories.

Long-read sequencing is gaining adoption for structural variants, repeat expansions, haplotype phasing, genome assembly, and metagenomics, while short-read platforms remain essential for cost-efficient oncology panels, exomes, transcriptomes, and high-volume sample processing. At the same time, regulatory-grade software, laboratory automation, sample-to-report workflows, interoperability, and quality management are becoming competitive differentiators as buyers prioritize reproducibility, compliance, and operational efficiency.

Cumulative Impact of Artificial Intelligence in NGS

Artificial intelligence is compounding the value of NGS by improving base calling, variant prioritization, annotation, quality control, and clinical interpretation. AI-enabled tools help reduce manual curation burden, identify sequencing artifacts, detect complex patterns in genomic and transcriptomic data, and accelerate the interpretation of large-scale genomic, epigenomic, and multiomic datasets.

The most significant impact is cumulative: each additional validated dataset can improve model performance, while each automated workflow can reduce turnaround time and cost per insight. In clinical environments, AI is particularly valuable for triaging variants of uncertain significance, linking genomic findings to phenotype data, supporting molecular tumor boards, and strengthening decision support. Governance remains critical, as algorithms must be validated, auditable, explainable where required, and aligned with privacy, cybersecurity, and medical-device requirements.

Key Regional Insights

North America remains a leading NGS region because of strong academic medical centers, advanced reference laboratory networks, biomedical funding, clinical trial activity, and broad adoption of oncology, rare disease, pharmacogenomics, and infectious disease sequencing. Europe benefits from national genomics strategies, mature biobank assets, cancer and rare disease programs, and regulation-led emphasis on data protection and clinical quality, with health-data initiatives expected to improve responsible cross-border data use over time.

Asia-Pacific is expanding as China, Japan, South Korea, India, Australia, and ASEAN economies invest in precision medicine, reproductive genomics, oncology testing, population genomics, and infectious disease surveillance. Latin America shows rising demand in Brazil and Mexico, supported by private diagnostics, academic collaborations, and expanding molecular laboratory capacity. The Middle East is advancing through national genome programs, preventive health strategies, and specialist hospital infrastructure, especially in Gulf countries, while Africa is building sequencing capacity through pathogen surveillance, human genomics initiatives, antimicrobial resistance monitoring, and regional research networks that improve genomic representation.

Key Group Insights

Among major economic and geopolitical groups, the G7 continues to lead in clinical adoption, reimbursement development, regulatory science, genomic medicine programs, and advanced sequencing infrastructure. The European Union is distinguished by coordinated health-data policy, genomics networks, rare disease collaboration, cancer mission priorities, and harmonized quality frameworks that support cross-country research and clinical implementation.

BRICS economies are increasingly important for high-volume sequencing demand, local manufacturing ambitions, biopharmaceutical research, and large-population genomic diversity. ASEAN markets are at varied stages, with Singapore and Thailand moving faster in clinical genomics and precision medicine adoption, while Indonesia, Vietnam, Malaysia, and the Philippines continue to expand laboratory capacity and workforce skills. GCC countries are investing in national genome initiatives, preventive medicine, population health, and specialized diagnostics, while NATO members benefit from strong biomedical research systems, biosecurity priorities, defense-related public health preparedness, and infectious disease surveillance capabilities.

Key Country Insights

The United States is a major NGS commercialization hub, supported by advanced diagnostics, biopharma demand, academic medicine, public health genomics, and large population research programs. Canada contributes through cancer genomics, newborn and rare disease initiatives, and publicly supported research networks, while Mexico and Brazil are strengthening private diagnostics, oncology testing access, and academic sequencing networks across Latin America.

In Europe, the United Kingdom, Germany, and France lead through national genomics programs, cancer strategies, rare disease frameworks, and industrial biotechnology capacity, while Italy and Spain are expanding hospital-based molecular testing and translational genomics. Russia maintains scientific capability in genomics and molecular biology but faces procurement, funding, and international collaboration constraints. In Asia-Pacific, China has substantial sequencing scale and population genomics activity, India is growing through affordability, disease diversity, and expanding diagnostic access, Japan and South Korea emphasize high-quality clinical adoption, oncology genomics, and advanced research infrastructure, and Australia supports genomics through public health programs, rare disease research, cancer genomics, and national research infrastructure.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize workflows that deliver measurable clinical, operational, or research outcomes rather than competing only on sequencing cost. Commercial success increasingly depends on end-to-end solutions that integrate sample preparation, sequencing, bioinformatics, reporting, data security, interoperability, quality assurance, and regulatory documentation.

Executives should build partnerships with hospitals, reference laboratories, biopharmaceutical developers, public health agencies, and national genomics programs to secure high-value use cases. Investment should focus on automation, AI-assisted interpretation, reimbursement evidence, decentralized testing support, workforce training, data governance, and compliance with evolving privacy, cybersecurity, and diagnostic regulations. Organizations that combine platform performance with trusted data interpretation, validated clinical evidence, and regionally adapted deployment models will be best positioned for durable growth.

Research Methodology

This executive summary is developed using secondary research from verified public sources, including regulatory agencies, national genomics programs, public health organizations, peer-reviewed literature, clinical guideline bodies, reimbursement references, government health-data initiatives, and published scientific collaborations. Market interpretation emphasizes documented technology adoption, policy direction, clinical use cases, regulatory context, and infrastructure investment.

The analysis applies a triangulated approach that compares platform trends, regional healthcare capacity, reimbursement maturity, research funding, regulatory readiness, laboratory infrastructure, and end-user demand across clinical diagnostics, pharmaceutical research, public health, agriculture, and academic genomics. Insights are synthesized to identify structural drivers, constraints, and strategic priorities without relying on unverified claims, market sizing, market share estimates, or unsupported projections.

Conclusion

Next generation sequencing is becoming a foundational technology for data-driven healthcare and life sciences. The market is no longer defined only by sequencing speed or cost; it is increasingly defined by the ability to convert genomic data into reliable, actionable, secure, and compliant decisions across clinical, research, public health, and industrial applications.

Adoption will be strongest where platforms, software, clinical evidence, reimbursement pathways, quality systems, and data governance align. As AI, long-read sequencing, multiomics, spatial biology, and population genomics mature, industry leaders that deliver validated workflows and regionally adapted strategies will be positioned to capture the highest-value opportunities in the global NGS ecosystem.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Next Generation Sequencing Market, by Technology

  • 7.1. Amplicon Sequencing
  • 7.2. Gene Panel Sequencing
  • 7.3. RNA Sequencing
  • 7.4. Targeted Sequencing
  • 7.5. Whole Exome Sequencing (WES)
  • 7.6. Whole Genome Sequencing (WGS)

8. Next Generation Sequencing Market, by Product Type

  • 8.1. Consumables Reagents
    • 8.1.1. Enzymes
    • 8.1.2. Kits
  • 8.2. Instruments
    • 8.2.1. Ancillary Instruments
    • 8.2.2. Sequencers
  • 8.3. Software
  • 8.4. Services

9. Next Generation Sequencing Market, by Read Length

  • 9.1. Short-Read
  • 9.2. Long-Read

10. Next Generation Sequencing Market, by End User

  • 10.1. Academic Research Institutes
  • 10.2. Healthcare Diagnostic Laboratories
  • 10.3. Pharmaceutical Biotechnology Companies

11. Next Generation Sequencing Market, by Application

  • 11.1. Agrigenomics
  • 11.2. Epigenomics
  • 11.3. Forensic Genomics
  • 11.4. Neurogenomics
  • 11.5. Oncology
  • 11.6. Pharmacogenomics

12. Next Generation Sequencing Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Next Generation Sequencing Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Next Generation Sequencing Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Illumina, Inc.
  • 16.2. Thermo Fisher Scientific, Inc.
  • 16.3. QIAGEN N.V.
  • 16.4. BGI Genomics Co., Ltd.
  • 16.5. Oxford Nanopore Technologies plc.
  • 16.6. Agilent Technologies, Inc.
  • 16.7. Bio-Rad Laboratories, Inc.
  • 16.8. Takara Bio Inc.
  • 16.9. Eurofins Genomics GmbH
  • 16.10. Pacific Biosciences of California, Inc.
  • 16.11. F. Hoffmann-La Roche Ltd
  • 16.12. Novogene Co., Ltd.
  • 16.13. MGI Tech Co., Ltd.
  • 16.14. GenScript Biotech Corporation
  • 16.15. 10x Genomics, Inc.
  • 16.16. DNAnexus, Inc.
  • 16.17. Element Biosciences, Inc.
  • 16.18. Fabric Genomics, Inc.
  • 16.19. Integrated DNA Technologies, Inc.
  • 16.20. Macrogen, Inc.
  • 16.21. PerkinElmer, Inc.
  • 16.22. PierianDx, Inc.
  • 16.23. SeqWell, Inc.
  • 16.24. Singular Genomics Systems, Inc.
  • 16.25. Strand Life Sciences Pvt. Ltd.
  • 16.26. Ultima Genomics, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL NEXT GENERATION SEQUENCING MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL NEXT GENERATION SEQUENCING MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL NEXT GENERATION SEQUENCING MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL NEXT GENERATION SEQUENCING MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL NEXT GENERATION SEQUENCING MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AMPLICON SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL GENE PANEL SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL GENE PANEL SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL GENE PANEL SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RNA SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RNA SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RNA SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL WHOLE EXOME SEQUENCING (WES) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL WHOLE GENOME SEQUENCING (WGS) MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CONSUMABLES REAGENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CONSUMABLES REAGENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CONSUMABLES REAGENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENZYMES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENZYMES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENZYMES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ANCILLARY INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ANCILLARY INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ANCILLARY INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL SEQUENCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL SEQUENCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SEQUENCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL SHORT-READ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL SHORT-READ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SHORT-READ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL LONG-READ MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL LONG-READ MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL LONG-READ MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL HEALTHCARE DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL HEALTHCARE DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL HEALTHCARE DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PHARMACEUTICAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PHARMACEUTICAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PHARMACEUTICAL BIOTECHNOLOGY COMPANIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AGRIGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AGRIGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AGRIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL EPIGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL EPIGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL EPIGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL FORENSIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL NEUROGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL NEUROGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL NEUROGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PHARMACOGENOMICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 87. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 88. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 89. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 91. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 92. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 93. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 94. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 95. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 96. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 97. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 98. NORTH AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 99. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 100. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 101. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 102. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 103. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 104. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 105. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 106. LATIN AMERICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 110. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 111. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 112. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 113. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 114. EUROPE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 117. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 119. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 120. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 121. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 122. MIDDLE EAST NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 124. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 125. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 127. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 128. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 129. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. AFRICA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. ASEAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 140. GCC NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 145. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 146. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 147. GCC NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPEAN UNION NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 160. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 161. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 162. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. BRICS NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 165. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 166. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 168. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 169. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 170. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. G7 NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 172. NATO NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 173. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 174. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 176. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 177. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 178. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 179. NATO NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL NEXT GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 183. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 185. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 186. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 187. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 188. UNITED STATES NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 190. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 191. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 192. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 193. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 194. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 195. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 196. CANADA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 198. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 199. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 201. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 202. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 203. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 204. MEXICO NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 205. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 206. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 209. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 210. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 211. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 212. BRAZIL NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 217. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 218. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 219. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED KINGDOM NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 221. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 222. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 223. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 224. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 225. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 226. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 227. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 228. GERMANY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 229. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 231. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 233. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 234. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 235. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. FRANCE NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 238. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 239. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 241. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 242. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 243. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 244. RUSSIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 245. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 246. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 247. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 249. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 250. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 251. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. ITALY NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 253. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 254. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 255. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 257. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 258. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 259. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. SPAIN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 261. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 262. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 263. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 265. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 266. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 267. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 268. CHINA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 269. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 270. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 271. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 273. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 274. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 275. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 276. INDIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 277. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 278. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 279. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 281. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 282. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 283. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 284. JAPAN NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 285. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 286. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 287. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 289. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 290. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 291. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 292. AUSTRALIA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 294. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 295. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY CONSUMABLES REAGENTS, 2018-2032 (USD MILLION)
  • TABLE 297. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 298. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY READ LENGTH, 2018-2032 (USD MILLION)
  • TABLE 299. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 300. SOUTH KOREA NEXT GENERATION SEQUENCING MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)